Opening Recap Market Pulse: Investors welcomed a wave of AI and robotics headlines, with talks of open-source robot OS and Qualcomm’s new AI board sparking

Minerva Neurosciences (NASDAQ: NERV), a clinical-stage biotech, is garnering fresh attention as it prepares to present at Stifel’s 2026 CNS Forum. The company’s lead drug

Overview: At the 2026 Game Developers Conference (GDC), Microsoft’s reveal of “Project Helix” – a next-gen Xbox designed to natively run both console and PC